Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Humalog

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
AIM To compare the pharmacokinetics (PK) and pharmacodynamics (PD) of 3 rapid-acting insulin lispro products: SAR342434 solution… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2009
2009
BACKGROUND This phase 1 study investigated the pharmacokinetics (PK) and glucodynamics of insulin lispro (Humalog; Eli Lilly and… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2004
2004
BACKGROUND Pregnancy outcome in diabetic women is strictly related to glycemic control during pregnancy. The aim of our study was… Expand
Is this relevant?
2003
2003
AIMS The use of insulin lispro in pregnancy has not been systematically investigated despite its increasing use. Pooled data from… Expand
Is this relevant?
2002
2002
BACKGROUND The objective of this study was to assess feature preferences, patient acceptance, reliability, and safety of the new… Expand
Is this relevant?
Highly Cited
2001
Highly Cited
2001
OBJECTIVE This study was performed to determine the effects of the Diabetes Control and Complications Trial (DCCT) report in 1993… Expand
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
1999
1999
Initially discovered in 1921, insulin was first made commercially available in 1923. Up until the early 1980s, all insulin… Expand
Is this relevant?
Highly Cited
1998
Highly Cited
1998
OBJECTIVE A precise time-action profile of insulin lispro (Humalog) at mealtime may reduce the incidence of severe hypoglycemia… Expand
Is this relevant?
1998
1998
Lipohypertrophy as a local complication of insulin therapy is well recognized. Despite improvements in insulin purity and the… Expand
Is this relevant?
1997
1997
OBJECTIVE The purpose of this study was to determine whether postprandial administration of the new rapid-acting insulin analog… Expand
Is this relevant?